This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinicaltrial data published in the European Journal of Pain.
The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.
” A separate study published in 2017 reported that U-Miss samples contain far lower levels of both THC and CBD than do commercially available cannabis. Clinicians wishing to conduct FDA-approved clinicaltrials on cannabis have long complained that federally-provided samples are of inferior quality.
According to a 2017 report published by the National Academies of Sciences , PTSD is a stressor-related disorder which develops as a result of a patient’s exposure to a traumatic event. The stress that results from traumatic events precipitates a spectrum of psycho-emotional and physiopathological outcomes.
The joint study conducted by Ben Gurion University and Soroka Medical Center in Beersheba analyzed 188 teens diagnosed with Autistic Spectrum Disorder (ASD) between 2015 and 2017. 2017) The current status of artisanal cannabis for the treatment of epilepsy in the United States. tetrahydrocannabinol (THC). improvement in good sleep.
Cann Group CEO Peter Crock said of the products: “Satipharm CBD capsules were one of the first medicinal cannabis products available to approved patients in Australia (under the Special Access Scheme) and have been successfully used in a variety of medical conditions since 2017.
The research Men’s Journal is referring to is the 2017 journal article published in Clinical Psychology Review titled: Medical cannabis and mental health : A guided systematic review. The authors conclude that: Mental health conditions are prominent among the reasons for medical cannabis use.
The 2017 study referenced by the authors indicated that “a majority of clinicians reported they lacked the formal training and knowledge of cannabis as a treatment alternative for Parkinson’s motor and non-motor symptoms.”
In 2017, The National Academies of Sciences, Engineering, and Medicine published a statement that the use of cannabis for the treatment of pain is supported by “well-controlled clinicaltrials and that there is substantial evidence that cannabis is an effective treatment for chronic pain in adults.”.
The country, which Tilray said has an estimated medical marijuana demand of more than 100,000 patients, legalized the drug for medical use in 2017 but has since relied on importing it. We do believe that there is an important role for clinicaltrials to play in terms of establishing the efficacy of the product,” Faltischek said. “We
In addition, data from the 2017 National Survey on Drug Use and Health showed a potential inverse relationship between marijuana and opioid use, based on data that reported a drop of opioid misuse from 2016 to 2017 (from 11.8 million to 11.4
Medical cannabis was legally approved in Germany in 2017 when approval was given for therapy-resistant symptoms in severely affected patients independent of diagnosis and without clinical evidence-based data,” lead investigator Professor Carsten Buhmann of the University Medical Center Hamburg-Eppendorf explained in a statement.
We look forward to providing continued updates on our intellectual property, research, clinical, regulatory and manufacturing activities for PD-001; our novel oral formulation of cepharanthine, with the aim of working towards a first-in-human, proof-of-concept clinicaltrial under an FDA IND approval.” Epub 2017 Aug 4.
It’s hard to get past decades of federal prohibition and criminalization, so it’s little wonder that in 2017 only three percent of adults over 65 years old reported being “current smokers.” [1]. “Americans Who Smoke Marijuana By Age Group 2017 | Statistic” 2018. Accessed December 5 2018. O’Neill, Stephanie.
Drug Enforcement Administration (DEA) granted permission for a Canadian marijuana company (Tilray) to export medicinal cannabis to University of California San Diego for clinicaltrial. As of 2017, Chinese companies hold more than half of the 606 patents filed around the world that relate to cannabis.
CBD first appeared on the natural channel’s top 40 list in 2017, ranking 12th, after sales growth of more than 300% from the previous year. million more on CBD products in 2021 compared to 2017 — a 413.4% Despite its top rank in 2021, sales of this ingredient have slowed in recent years. Consumers spent roughly $31.3
The study, titled Pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial , was first published by NORML. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo.
Then, in November 2019, the FDA granted the designation to the nonprofit Usona Institute to study psilocybin’s effect on major depressive order, for which clinicaltrials are currently under way. See Usona Institute, A Study of Psilocybin for Major Depressive Disorder (MDD) , ClinicalTrial ID NCT03866174, available at [link].
More clinicaltrials are needed to establish definitive efficacy and safety profiles. 2017 Study Published in “Cannabis and Cannabinoid Research” – Findings: This study found that medical cannabis users experienced significant reductions in headache and migraine frequency. .
DoobTool was created in Halifax, Nova Scotia in 2017, with the “active cannabis consumer in mind” and the goal of “breaking through the stoner stereotypes,” according to the company website. Will the DoobTool make you feel like a survivalist? The Hydrology9 NX: A water vape? Is it a bong? Is it a vaporizer? sorta both?
The researchers stated that these knowledge gaps must be addressed and that “clinicaltrial data about how medical cannabis improves patient quality of life domains is desperately needed as this information can impact clinical decision-making.”.
A 2017 review of existing studies by researchers Suzanna Nielsen of Australia’s University of New South Wales and Michael Farrell of the country’s National Drug and Alcohol Research Centre suggested that when co-administered with opioids, cannabis may enable reduced opioid doses without decreasing the pain relief. MAINE STUDY PROMISING.
We analyzed annual administrations of TSCI from 2013–2017, which asked respondents about various dimensions of traffic safety, including driving after marijuana use [ 28 ]. Between 2013 and 2017, approximately 3000 TSCI surveys were completed annually. 2017 Traffic Safety Culture Index: AAA Foundation for Traffic Safety; 2018.
The double-blind, randomised, placebo-controlled clinicaltrial took place over two years between 2017 and 2019 at the Center for Medicinal Cannabis Research at the University of California. medical cannabis users at risk of unfair prosecution, according to a report by Volteface.
One such breakthrough in research came back in 2017, when researchers found strong evidence that cannabis could help treat dementia. Now, clinical studies are about to get underway at an Australia university, to track changes in actual dementia patients to see if cannabis can help. But in recent years, new research both in the U.S.
Similar to ketamine, psilocybin has shown great promise in clinicaltrials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ). Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine.
This year, we are completing the second Phase 3 clinicaltrial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.
Clinicaltrials repeatedly demonstrate their promise for treating mood, anxiety, and substance use disorders. In 2017, the FDA designated MDMA a breakthrough therapy for post-traumatic stress disorder, and in 2018 the agency identified psilocybin as a breakthrough for treatment-resistant depression.
MDMA has also reportedly been used with over 1,000 individuals in clinicaltrials , with no adverse effects to report. . The world’s first trial for MDMA as a treatment for alcohol addiction was published in 2017. Consuming Therapeutically and Recreationally. MDMA is a popular recreational drug that is consumed orally.
Clinicaltrials are also underway to determine the possibility of THC, cannabis, and other cannabinoids to help with obesity and appetite. A study released in 2017 by the National Academies of Sciences, Engineering, and Medicine showed the health effects of cannabinoids and cannabis. THC Oil Effects.
Dr Gulbransen commented that if the audit results should be borne out by clinicaltrials, subsidising medical cannabis should be considered. Of the first 400 patients at his clinic, 62 chose not to take CBD oil – and one of the reasons was cost. New Zealand’s government eased restrictions on cannabidiol in 2017.
A 2017 review of 10 clinicaltrials found that people who took probiotics had a 14% lower risk of contracting a cold or flu. He adds that research has shown that probiotics can help the immune system produce more antibodies to fight off viruses and bacteria. Probiotics May Reduce Flu Risk.
Lack of clinicaltrials is a major reason why doctors are cautious about the drug. In January 2017, the German Parliament passed a reform of the country’s drug law, allowing easier access to cannabis products for therapeutic purposes. Before the law was changed, only 1,000 patients were prescribed with medical cannabis.
“The licence enables our strategic alliance with RMIT to advance on its objective to establish a world first library of cannabis medicines, as well as conducting ground-breaking pre-clinical research into the positive effects that medicinal cannabis may have on specific cancers.”.
Several other observational trials have similarly reported that those with a cannabis use history possess lower BMI , and are less likely to be obese or suffer from adult onset diabetes as compared to non-users.
The Victorian and New South Wales Governments had both begun clinicaltrials of cannabis products for children with severe epilepsy and for palliative care, respectively. The clinicaltrials and the standard of production could lead the world.”.
The approval is based on the research and clinicaltrials. However, a study published in 2017 found that the use of CBD results in fewer seizures among children with Dravet syndrome, as compared to placebo. CBD occurs in cannabis. Moreover, it is not psychoactive.
The joint study conducted by Ben Gurion University and Soroka Medical Center in Beersheba analyzed 188 teens diagnosed with Autistic Spectrum Disorder (ASD) between 2015 and 2017. 2017) The current status of artisanal cannabis for the treatment of epilepsy in the United States. tetrahydrocannabinol (THC). improvement in good sleep.
” Clinicaltrial data published in 2017 in in the journal European Neuropsychopharmacology previously reported that the administration of whole-plant cannabis extracts is associated with improvements in cognition and behavior in subjects with ADHD.
million dollar grant from the National Institute on Drug Abuse in 2017 to conduct a 5-year study on the effects of cannabis on HIV. But I haven’t seen any clinicaltrials looking at the direct effects of THC on the virus. Biggest cannabis/HIV study is yet to come. University of Florida received a 3.2
Drug interactions reported in the scientific literature most often occur at very high doses used in clinicaltrials of epilepsy and other conditions. The Journal of Clinical Pharmacology 60.4 2017): 1586-1592. 2020): 432-438. Gaston, Tyler E., Interactions between cannabidiol and commonly used antiepileptic drugs.”
It’s when presented with personal stories like that of the Rhodes family and the stream of alarming data that the significance of Tetra Bio-Pharma’s (TBP) clinicaltrials is worth exploring. Can medical cannabis be the solution?
World Drug Report ‘s estimation that 18 million people between 15 and 64 years of age consumed cocaine in 2017. Note: No human studies were found (with the exception of one clinicaltrial that was ongoing and therefore not selected); all studies focused on animals (i.e., mice/rats).
Some patients put faith in anecdotal reports or the encouraging results of observational studies, but anecdotal reports and observational studies are not double blind randomized controlled clinicaltrials and do not prove that a treatment is or is not effective. Meredith Fisher-Corn, MD, along with Stephen B.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content